Myositis ossificans progressiva, unspecified foot
ICD-10 M61.176 is a billable code used to indicate a diagnosis of myositis ossificans progressiva, unspecified foot.
Myositis ossificans progressiva (MOP) is a rare genetic disorder characterized by the abnormal formation of bone in muscles and connective tissues. This condition typically begins in early childhood and progresses over time, leading to significant muscle stiffness and weakness. In the case of unspecified foot involvement, patients may experience pain, swelling, and reduced mobility in the affected foot due to the ossification process. The condition is caused by mutations in the ACVR1 gene, which plays a crucial role in bone growth and development. Diagnosis is often made through clinical evaluation, imaging studies, and genetic testing. Patients may present with episodes of soft tissue swelling followed by the development of bony masses, which can severely limit joint movement and function. Management focuses on symptomatic relief, physical therapy, and avoiding trauma to the affected areas, as injury can exacerbate ossification. Understanding the nuances of myositis ossificans progressiva is essential for accurate coding and effective patient management.
Detailed clinical notes on symptoms, progression, and treatment response.
Patients presenting with muscle stiffness and swelling, particularly after trauma.
Documentation should include family history and genetic testing results.
Genetic test results and family pedigree charts.
Patients with a family history of myositis ossificans or unexplained ossification.
Ensure clear linkage between genetic findings and clinical symptoms.
Used for follow-up visits for management of myositis ossificans.
Document patient history, examination findings, and treatment plan.
Rheumatology specialists should ensure comprehensive notes on symptom progression.
Myositis ossificans progressiva is a rare genetic disorder characterized by the abnormal formation of bone in muscles and connective tissues, leading to progressive disability.